- Muutos BBS-Bioactive Bone Substitutes Oyj:n johtoryhmässä
- Changes in BBS-Bioactive Bone Substitutes Plc’s Management Team
- BBS-Bioactive Bone Substitutes Plc: Financial Statements Bulletin 2023: Preparations for commercial phase initiated (unaudited)
- BBS-Bioactive Bone Substitutes Oyj: Tilinpäätöstiedote 2023: Kaupallisen vaiheen valmistelut alkaneet (tilintarkastamaton)
- Inside information - BBS-Bioactive Bone Substitutes Plc: Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and RiverFort to strengthen the working capital position
- Sisäpiiritieto - BBS-Bioactive Bone Substitutes Oyj on sopinut RiverFortin kanssa rahoitussopimuksen mukaisen ennakkomaksun kolmannen erän nostamisesta yhtiön käyttöpääoman vahvistamiseksi
- BBS-Bioactive Bone Substitutes Oyj on päättänyt maksuttomasta osakeannista itselleen
- BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself
- BBS-Bioactive Bone Substitutes Plc: Kimmo Tyni appointed as Product Director of BBS-Bioactive Bone Substitutes Plc
- BBS-Bioactive Bone Substitutes Oyj: Kimmo Tyni nimitetty BBS-Bioactive Bone Substitutes Oyj:n tuotantojohtajaksi
More ▼
Key statistics
On Thursday, BBS-Bioactive Bone Substitutes Oyj (BONEH:HEX) closed at 0.346, 28.15% above the 52 week low of 0.270 set on Jun 18, 2024.
52-week range
Open | 0.331 |
---|---|
High | 0.346 |
Low | 0.32 |
Bid | -- |
Offer | -- |
Previous close | 0.331 |
Average volume | 18.30k |
---|---|
Shares outstanding | 20.30m |
Free float | 13.49m |
P/E (TTM) | -- |
Market cap | 6.72m EUR |
EPS (TTM) | -0.2926 EUR |
Data delayed at least 15 minutes, as of Jul 04 2024 17:00 BST.
More ▼